Spinal Stabilization Technologies

Spinal Stabilization Technologies

Dublin, Ireland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Spinal Stabilization Technologies is a clinical-stage medical device company pioneering a novel, less invasive approach to treating discogenic low back pain through nucleus replacement. Its core technology, the PerQdisc™ system, is an in-situ formed silicone-based prosthesis designed to replace the diseased nucleus pulposus, emulate its natural biomechanics, and redistribute spinal loads. The company is currently advancing the PerQdisc through a series of clinical trials (N161, N181, LOPAIN, DISCPAIN1) to demonstrate safety and efficacy, with the device not yet approved for commercial sale in key markets like the US or CE-mark regions.

OrthopedicsChronic Pain

Technology Platform

In-situ formed silicone-based nucleus pulposus replacement system designed to emulate native disc biomechanics and enable less invasive, motion-preserving spine surgery.

Opportunities

The PerQdisc addresses a massive unmet need in the multi-billion dollar spine surgery market by offering a potentially less invasive, motion-preserving alternative to fusion or total disc replacement.
Successful clinical validation could position the company for acquisition by a major orthopedic firm or a targeted commercial launch in key markets.

Risk Factors

High clinical and regulatory risk, as the device must prove safety and efficacy in ongoing trials to gain FDA/CE approval.
The company faces significant commercial competition from established spine players and the historical challenge of commercializing nucleus replacement technologies.

Competitive Landscape

SST competes in the dynamic spine implant market against giants like Medtronic, Stryker, and Johnson & Johnson, who offer fusion and total disc replacement systems. It also faces competition from other nucleus replacement developers (e.g., Zimmer Biomet's NuCore, prior attempts like the DASCOR) and emerging motion-preserving technologies like annulus repair devices and dynamic stabilization systems.